$ITOS iTeos Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in iTeos Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in iTeos Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in iTeos Therapeutics, Inc. for free.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ITOS
Company Address: 139 MAIN STREET CAMBRIDGE 02142
Phone number: 857-204-4583
iTeos Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2021 | ITOS | iTeos Therapeutics ... | Gall Matthew | Chief Financial Off ... | Option Exercise | A | 23.19 | 24,000 | 556,560 | 24,000 | |
| Jun 21 2021 | ITOS | iTeos Therapeutics ... | DiRocco Derek | Director | Option Exercise | A | 26.03 | 16,608 | 432,306 | 0 | |
| Jun 21 2021 | ITOS | iTeos Therapeutics ... | Van Hauwermeiren Timothy | Director | Option Exercise | A | 26.03 | 16,608 | 432,306 | 0 | |
| Jun 21 2021 | ITOS | iTeos Therapeutics ... | Ho Tony W | Director | Option Exercise | A | 26.03 | 4,560 | 118,697 | 4,560 | |
| Jun 16 2021 | ITOS | iTeos Therapeutics ... | Detheux Michel | Chief Executive Off ... | Sell | S | 29.26 | 3,937 | 115,199 | 148,937 | 152.9 K to 148.9 K (-2.58 %) |
| Jun 16 2021 | ITOS | iTeos Therapeutics ... | Detheux Michel | Chief Executive Off ... | Sell | S | 28.38 | 25,063 | 711,336 | 152,874 | 177.9 K to 152.9 K (-14.09 %) |
| May 03 2021 | ITOS | iTeos Therapeutics ... | Iannone Robert | Director | Option Exercise | A | 24.11 | 33,217 | 800,862 | 0 | |
| May 03 2021 | ITOS | iTeos Therapeutics ... | Ho Tony W | Director | Option Exercise | A | 24.11 | 33,217 | 800,862 | 0 | |
| Apr 13 2021 | ITOS | iTeos Therapeutics ... | MPM BioVentures 2014, L.P. | 10% Owner | Sell | S | 29.99 | 119 | 3,569 | 3,665,787 | 3.7 M to 3.7 M (0.00 %) |
| Apr 13 2021 | ITOS | iTeos Therapeutics ... | MPM BIOVENTURES 2018, L.P. | 10% Owner | Sell | S | 29.99 | 119 | 3,569 | 3,665,787 | 3.7 M to 3.7 M (0.00 %) |
| Apr 13 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | S | 29.99 | 200 | 5,998 | 6,004,368 | 6 M to 6 M (0.00 %) |
| Apr 09 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | S | 31.01 | 414 | 12,838 | 6,004,568 | 6 M to 6 M (-0.01 %) |
| Apr 09 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | S | 30.51 | 31,890 | 972,964 | 6,004,982 | 6 M to 6 M (-0.53 %) |
| Apr 09 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | S | 31.01 | 414 | 12,838 | 6,004,568 | 6 M to 6 M (-0.01 %) |
| Apr 09 2021 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | 10% Owner | Sell | J | 0.00 | 15,670 | 0 | 6,036,872 | 6.1 M to 6 M (-0.26 %) |